Doctor-Prescribed GLP-1 Weight Loss & Wellness — Delivered Free to Your Door

Competitive Flat-Rate Pricing With No Upcharges at Higher Doses

Tmates' compounded semaglutide starts at $249/month and compounded tirzepatide at $297/month — both below the market average. The pricing model that genuinely sets Tmates apart: every dosage tier from starting dose to maximum dose is included at that same flat rate. When your physician increases your dose during the titration process (which happens gradually over months as your body adjusts), your bill stays the same. Most competitors charge more at higher doses, meaning what looks affordable at entry becomes more expensive at therapeutic doses. Tmates eliminates that pricing risk entirely.

Bundle pricing adds meaningful savings for patients committing to a full program: the 12-month semaglutide plan drops to $158/month, saving 37% versus month-to-month. The 12-month tirzepatide plan drops to $167/month — a 44% saving. Even the 3-month bundle on tirzepatide saves $30/month per bottle. For patients who plan to be on GLP-1 therapy for 6–12 months (which clinical evidence increasingly supports as the appropriate duration for sustained results), these savings are substantial.

Both Injectable AND Oral Formats for Both GLP-1s

Most GLP-1 telehealth platforms offer injectable semaglutide and, increasingly, oral alternatives — but very few offer both injectable and oral formulations for both semaglutide and tirzepatide at the same price. Tmates' compounded GLP-1's dual-format availability means patients who are uncomfortable with injections can start with oral formulations, and those who want maximum clinical efficacy can choose injectable — all at the same $249/$297 monthly price. This flexibility is a meaningful differentiator that affects patient adherence and outcomes.

Real Board-Certified Physicians, Not Automated Approval

Tmates explicitly states "real humans create personalized plans" — a direct contrast with platforms that use algorithmic screening to approve prescriptions. Every Tmates patient case is reviewed by a board-certified US physician licensed in that patient's state, who evaluates their health history, current medications, contraindications, and treatment goals before making an independent prescribing decision. The physician relationship continues through ongoing check-ins and dose adjustments throughout the treatment course.

Labs Included With TRT — No Hidden Bloodwork Costs

Tmates' testosterone cypionate TRT program includes lab work in every plan. Required bloodwork to confirm eligibility and monitor testosterone levels during treatment is bundled into the $200/month flat rate — no surprise bills for the lab draws that are medically required for safe TRT. This is genuinely unusual in the telehealth market, where most TRT providers charge $50–$150 separately for required lab work.

Full Refund Policy — Zero Risk to Check Eligibility

If a licensed physician reviews your intake and determines you're not an appropriate candidate for treatment, you receive a complete refund. No partial fees, no "consultation charges." This policy means the financial risk of the eligibility determination falls on Tmates rather than the patient — removing a significant friction point that deters people from trying telehealth programs they're genuinely eligible for.

The Broadest Treatment Catalog in Telehealth

No other telehealth platform in 2026 combines compounded GLP-1 weight loss (oral and injectable), brand-name prescription management (Wegovy® and Zepbound®), NAD+ anti-aging injections, testosterone replacement with labs, ED support, prescription hair loss treatment, and prescription-strength skin care — all under one patient relationship. This breadth matters for patients managing multiple health concerns: a patient on semaglutide who also wants NAD+ therapy or TRT doesn't need to establish a separate telehealth relationship, go through another intake process, or manage another subscription. Explore the full Tmates treatment catalog to see all 11 products.

Transparent Compounding Disclosures

Tmates explicitly discloses that compounded medications "are not evaluated by the FDA for safety, quality or efficacy" — a disclosure required by regulatory compliance and indicative of a platform operating within legal boundaries. Some competitors blur the distinction between compounded and FDA-approved products in ways that mislead patients. Tmates' transparency allows patients to make genuinely informed decisions about their treatment. The Wegovy® ($99/mo) and Zepbound® ($99/mo) prescription management services exist precisely for patients who specifically want FDA-approved branded medications.

4.9/5 Patient Rating on ConsumerHealthDigest

As of August 2026, Tmates holds a 4.9/5 rating on ConsumerHealthDigest based on verified patient reviews. Testimonials document losses of 20–47 lbs across multiple patients. ConsumerHealthDigest's individual score breakdown: 4.8/5 Ingredients, 4.7/5 Value for Cost, 4.6/5 Manufacturer, 4.7/5 Safety. Read patient testimonials and the full Tmates review 2026 for independent third-party analysis.

Semaglutide: GLP-1 Receptor Agonism

GLP-1 (glucagon-like peptide-1) is a gut hormone naturally secreted after eating, whose job is to signal the brain that the meal is complete. In people with obesity, this signaling system is chronically blunted — hunger signals are strong and persistent regardless of recent caloric intake, creating the biological drive that makes sustained caloric restriction so difficult without medication.

Tmates weight loss's compounded semaglutide is a GLP-1 receptor agonist: a synthetic molecule that mimics GLP-1 at sustained therapeutic levels. It targets appetite centers in the hypothalamus, slows gastric emptying so food stays in the stomach longer, and — critically — reduces the persistent mental preoccupation with food that patients describe as "food noise." This noise elimination, rather than willpower, is what allows GLP-1 patients to sustain reduced caloric intake without the constant psychological effort that conventional dieting requires.

The STEP-1 clinical trial (NEJM 2021) documented 14.9% average body weight loss over 68 weeks. 86.4% of participants lost ≥5% of body weight; 69.1% lost ≥10%. These results represent the strongest long-term pharmacological weight loss outcomes in clinical literature prior to tirzepatide's arrival. Read the full semaglutide vs tirzepatide comparison for a detailed trial data breakdown.

Tirzepatide: Dual GLP-1/GIP Action

Tmates' doctor-supervised program's compounded tirzepatide adds a second mechanism: GIP (glucose-dependent insulinotropic polypeptide) receptor agonism. GIP receptors are densely expressed in adipose tissue and work in concert with GLP-1 receptors to produce more comprehensive metabolic regulation than GLP-1 alone. The SURMOUNT-1 trial (NEJM 2022) documented 22.5% average body weight reduction at 15mg over 72 weeks — the largest pharmacological weight loss ever recorded in a major clinical trial. At that dose, 57% of participants achieved ≥20% weight loss — a threshold previously achievable only through bariatric surgery.

Tirzepatide also produces superior improvements in insulin sensitivity and triglycerides compared to semaglutide — making it particularly valuable for patients with metabolic syndrome, PCOS, or prediabetes. See the full weight loss category to compare all available options.

NAD+ Injections: Restoring Cellular Energy

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell, central to ATP energy production, DNA repair, and longevity signaling through sirtuin proteins. NAD+ levels decline approximately 50% between ages 40 and 60 — a decline correlated with fatigue, cognitive fog, slower recovery, and accelerated cellular aging.

Tmates medical weight loss's injectable NAD+ therapy ($149/mo) bypasses the limited bioavailability of oral NAD+ precursors by delivering 1000mg directly into circulation subcutaneously. Unlike IV infusions (which require clinic visits at $300–$600/session), subcutaneous injection achieves high bioavailability at home. Patients typically report energy improvements within 2–4 weeks. Explore the full anti-aging category including Sermorelin for natural HGH stimulation.

Testosterone Cypionate: Hormone Restoration

Testosterone declines approximately 1–2% annually after age 30. For men with clinically confirmed low testosterone, start with Tmates's TRT program ($200/mo, labs included) restores physiological testosterone levels through weekly or biweekly subcutaneous testosterone cypionate injections — improving energy, muscle mass, libido, mood, and cognitive function. Lab work is bundled in every plan. Explore men's health treatments including the combination of TRT and ED support.

Minoxidil & Hydroquinone: Prescription-Strength Topicals

Minoxidil 5% foam ($80/mo) extends the hair follicle growth phase and increases follicle blood flow — one of only two clinically proven hair loss treatments. Prescription 5% hydroquinone cream ($40/order) inhibits tyrosinase-driven melanin production, gradually lightening hyperpigmentation, melasma, and post-inflammatory dark spots to match surrounding skin. Both require physician oversight at prescription concentrations — which Tmates provides through its telehealth model. Browse hair growth and skin care categories.

Clinically Significant Weight Loss — Quantified by Major Trials

The primary benefit is the one patients seek most: sustained, clinically significant weight reduction at a magnitude that diet alone cannot reliably produce. Tmates' semaglutide program is backed by STEP-1's 14.9% average body weight loss at 68 weeks. The tirzepatide program is backed by SURMOUNT-1's 22.5% average at 72 weeks — the largest pharmacological weight loss ever recorded. For a 250-pound patient, these averages translate to 37 and 56 pounds respectively. Tmates claims up to 33 lbs in 4 months, consistent with early responder data at adequate doses.

Elimination of Food Noise — The Most Underrated GLP-1 Benefit

The subjective experience patients describe most consistently and most powerfully is the disappearance of "food noise" — the constant mental preoccupation with eating, cravings, and what comes next. This background mental chatter about food is exhausting, it consumes cognitive bandwidth, and it is what makes caloric restriction feel like permanent willpower exercise for people with obesity. GLP-1 medications normalize the appetite biology underlying this experience. Patients don't just eat less; they think about food less, want food less, and find portion control natural rather than effortful. This is qualitatively different from the experience of dieting without medication.

Cardiovascular Risk Reduction — Beyond Weight Loss

The SELECT trial (NEJM 2023) demonstrated that semaglutide reduced major adverse cardiovascular events — heart attacks, strokes, cardiovascular deaths — by 20% in overweight adults without diabetes. This benefit appeared independent of weight loss alone, suggesting GLP-1 medications have direct cardioprotective mechanisms. For overweight and obese patients with cardiovascular risk factors, this extends the clinical value of semaglutide beyond metabolic outcomes.

Blood Sugar Normalization in Prediabetic Patients

Both semaglutide and tirzepatide were originally developed as diabetes medications. In clinical trials of prediabetic patients, a substantial proportion normalized their blood glucose during treatment — reverting from prediabetic to normal glucose regulation. The SURMOUNT-4 tirzepatide trial and STEP-5 semaglutide trial both documented this effect. For the 96 million US adults with prediabetes, this represents a meaningful secondary benefit alongside weight management. See GLP-1 for prediabetes and GLP-1 for metabolic syndrome.

Additional Benefits Across Tmates' Full Catalog

• NAD+ injections ($149/mo): Improved cellular energy, enhanced mental clarity, faster post-exercise recovery, and cellular repair support — benefits that typically begin within 2–4 weeks. Read the NAD+ injection benefits guide.
• Testosterone TRT ($200/mo, labs incl.): Restored energy and stamina, increased lean muscle mass, improved libido and sexual function, mood stabilization, and cognitive clarity for men with clinically low testosterone.
• Sermorelin ($179/mo): Enhanced sleep quality (often within 2–3 weeks of starting), improved body composition, faster recovery from exercise, and natural HGH stimulation without synthetic hormone administration risks.
• Minoxidil 5% ($80/mo): Slowed hair loss progression and promoted hair regrowth visible from 3–6 months of consistent use. One of only two clinically proven treatments for androgenic alopecia. View hair growth category.
• Hydroquinone 5% cream ($40/order): Gradual, targeted lightening of hyperpigmentation, melasma, age spots, and post-inflammatory dark marks — visible results from 6–8 weeks of consistent daily use with SPF. View skin care category.
• ED support ($48/order): Fast-acting Sildenafil combined with longer-lasting Tadalafil for broader coverage than either medication alone, at a far lower cost than branded alternatives. View men's health category.